Non classé

DiCE Joins Call for Urgent Action: Open Letter to President von der Leyen Demands EU4Health 2025 Clarity

DiCE has joined 34 health NGOs urging President von der Leyen to adopt the delayed EU4Health 2025 Work Programme. Immediate action is needed to sec...

Read

PRESSURE Consortium: Addressing Therapy Resistance in Oesophageal Adenocarcinoma

The PRESSURE Consortium unites experts across Europe to address therapy resistance in oesophageal adenocarcinoma. Through advanced research models,...

Read

Don’t Say “Later” – Early Screening Can Save Lives

Colorectal cancer diagnoses are rising in Lithuania. Despite screening efforts, low participation costs lives. Experts call for stronger awareness,...

Read

EuropaColon Latvia Strengthens Its Impact with DiCE Support

Awareness materials, a Christmas campaign for chemotherapy patients, and community walks in Riga—combined with promotion of the DiCE StepApp—hi...

Read

Strengthening Patient Advocacy: DiCE Team Training with Stefan Gijssels

DiCE hosted three days of training in Brussels, with Stefan Gijssels leading a powerful session on patient advocacy. The team collaborated in dynam...

Read

Strengthening Global Collaboration: DiCE CEO Visits Mexico to Support FUTEJE

In March, DiCE CEO Zorana Maravic visited Mexico as Special Advisor for the GCCA, collaborating closely with FUTEJE to enhance colorectal cancer pa...

Read

Turning Potential into Action: How Biosimilars Can Reshape Access and Outcomes in Cancer Care

At BIOS25 in Amsterdam, DiCE highlighted patient perspectives on biosimilars. CEO Zorana Maravic underscored the urgent need to overcome barriers, ...

Read

Current Board Members Share Their Experiences

At Digestive Cancers Europe (DiCE), our Board Members are crucial in guiding and supporting our mission to improve the lives of patients affected b...

Read

Call for Board Candidates – Help Shape DiCE’s Future!

We’re seeking two dedicated representatives from our Full Member Organisations to shape DiCE’s future strategy and governance. Apply by May 23 ...

Read

DiCE Supports Patient-Led Progress at the Biosimilar Medicines Conference 2025

At BIOS25 in Amsterdam, DiCE joined leading voices to champion patient-centred biosimilar policy. CEO Zorana Maravic called for reinvestment of sav...

Read

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.